SCHEMBL1940988

SCHEMBL1940988

Nc1cccc(CCN2C(=O)c3ccccc3C2=O)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.59
GAA P10253 3/20 0.56
ALDH1A1 P00352 3/20 0.56
MAPT P10636 2/20 0.56
RAB9A P51151 2/20 0.56
KDM4E B2RXH2 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA4 P22748 1/20 0.54
CA9 Q16790 1/20 0.54
MAOA P21397 2/20 0.53
MAOB P27338 2/20 0.53
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
CYP1B1 Q16678 1/20 0.49
SIGMAR1 Q99720 1/20 0.49
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
CYP19A1 P11511 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2157305 0.91 TDP1 (0.60) CASP3ALDH1A1MAOAMAOBTDP1
SCHEMBL18041403 0.88 TDP1 (0.70) TDP1L3MBTL1CYP1B1
SCHEMBL20819273 0.84 RAB9A (0.44) CASP3GAAALDH1A1MAPTRAB9A
SCHEMBL21147092 0.84 CASP3 (0.59) CASP3GAAALDH1A1MAPTRAB9A
SCHEMBL2025369 0.83 KMT2A (0.60) CASP3GAAALDH1A1MAPTKDM4E
SCHEMBL10661191 0.83 CASP3 (0.62) CASP3GAAALDH1A1MAPTRAB9A
SCHEMBL1946531 0.81 CA1 (0.67) CASP3GAAALDH1A1MAPTRAB9A
SCHEMBL29531639 0.81 CA1 (0.67) CASP3GAAALDH1A1MAPTRAB9A
SCHEMBL29724090 0.81 CASP3 (0.86) CASP3GAAALDH1A1MAPTRAB9A
SCHEMBL1142116 0.81 CASP3 (0.86) CASP3GAAALDH1A1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2330909-B1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2013-09-18 EP disclosed
US-8383635-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2013-02-26 US disclosed
EP-2330909-A1 CHEMICAL COMPOUNDS GlaxoSmithKline LLC (US) 2011-06-15 EP disclosed
US-20110136838-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2011-06-09 US disclosed
WO-2010019637-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2010-02-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110136838-A1 CHEMICAL COMPOUNDS PDK1, PDK4, PDK3 CASP3 3673/4885GAA 1498/4885ALDH1A1 572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.